Collaborate for industry

Our pipeline database relies on information provided by pharmaceutical partners.

Click here for more information on how to contribute.

Join for research labs

Database access is free-of-charge and granted only to non-profit or academic research.

Click here to start setting up a DrugPath account.

About DrugPath

Click here to meet the people involved with DrugPath.

Terms of Use

Access to DrugPath is provided free-of-charge. Users of DrugPath must be members of the academic and/or non-profit research community.

Any resulting publications involving the use of DrugPath must include a citation of the DrugPath resource.

Shah ED, Fisch BM, Arceci RJ, Buckley JD, Reaman GH, Sorensen PH, Triche TJ, Reynolds CP. DrugPath: a database for academic investigators to match oncology molecular targets with drugs in development. Cancer Chemotherapy and Pharmacology. 2014: 73(5); 1089-93.

Shah ED1, Fisch BM, Arceci RJ, Buckley JD, Reaman GH, Sorensen PH, Triche TJ, Reynolds CP.

Users do not have permission to redistribute DrugPath data for purposes other than academic research without specific, written prior authorization.

By breaching any of these terms, authorization to use DrugPath will be immediately terminated, and the non-compliant user must immediately destroy any downloaded or printed materials.

Access and use is provided as is, without representation as to its fitness for any purpose, and without warranty of any kind, either express or implied, including without limitation the implied warranties of merchantability and fitness for a particular purpose. DrugPath, Texas Tech University System, the Department of Defense and Children's Oncology Group are never liable for any damages whatsoever arising during the use of or inability to use this site.

Users must also have read and agree to the terms of use for the Michigan Molecular Interactions database.

Login

Log in
  • Username:
  • Password:

Statistics

statistics

The DrugPath database contains information on:

  • 2081 Drugs
  • 751 Companies
  • 722 Targets